PHASE4 VENTURES
Phase4 Ventures is a venture capital firm based in London that invests in development stage life science companies in the US and Europe. Founded in 1999, the team has made close to 30 investments in Life Science companies alongside other top tier venture capital firms in both Europe and the US. The team is complemented by an extensive group of advisors with operating experience at a senior level in pharmaceutical and biotechnology companies. Phase4 Ventures' investments include many of the compa... nies that have provided successful European and US venture exits including Intercell, Pharmion, Targacept and most recently Proteolix. Phase4 Ventures was spun-out from Nomura in December 2010 following a buy out of the management company by the team and a secondary purchase of a fund by HarbourVest Partners. Phase4 Ventures currently manages funds for both Nomura and HarbourVest. Phase4 Ventures Limited is a member of the British Private Equity and Venture Capital Association (BVCA) and the European Private Equity and Venture Capital Association (EVCA).
PHASE4 VENTURES
Industry:
Finance Financial Services Venture Capital
Founded:
1999-01-01
Status:
Closed
Contact:
44 203 036 0050
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2009-08-06 | Zosano Pharma | Phase4 Ventures investment in Series B - Zosano Pharma | 30 M USD |
| 2008-11-04 | OncoMed Pharmaceuticals | Phase4 Ventures investment in Series B - OncoMed Pharmaceuticals | 154 M USD |
| 2008-09-08 | Proteolix | Phase4 Ventures investment in Series C - Proteolix | 79 M USD |
| 2007-11-15 | Zosano Pharma | Phase4 Ventures investment in Series A - Zosano Pharma | 90 M USD |
| 2007-09-04 | Nabriva Therapeutics | Phase4 Ventures investment in Venture Round - Nabriva Therapeutics | 56 M USD |
| 2007-03-08 | Phenomix | Phase4 Ventures investment in Series C - Phenomix | 55 M USD |
| 2006-04-03 | Chroma Therapeutics | Phase4 Ventures investment in Series C - Chroma Therapeutics | 53 M USD |
| 2006-02-10 | ARYx Therapeutics | Phase4 Ventures investment in Series E - ARYx Therapeutics | 30.4 M USD |
| 2005-10-26 | Cerimon Pharmaceuticals | Phase4 Ventures investment in Series A - Cerimon Pharmaceuticals | 70 M USD |
| 2004-06-01 | ARYx Therapeutics | Phase4 Ventures investment in Series D - ARYx Therapeutics | 55 M USD |
More informations about "Phase4 Ventures"
Phase 4 Partners - Phase4 Ventures
At Phase4 Ventures, we believe in the power of innovation to revolutionize healthcare. Led by Managing Partner Denise Pollard-Knight, we are a venture capital firm dedicated to investing …See details»
Phase 4 Partners
Phase4 Ventures is a venture capital firm specializing in early-stage and growth-stage investments in the healthcare sector. Founded and led by Denise Pollard-Knight, a seasoned …See details»
Phase4 Partners - Crunchbase Investor Profile
Long known as one of the leading life science venture capital firms based in Europe, Phase4 Partners, formerly known as Phase4 Ventures,See details»
Phase4 Ventures - Products, Competitors, Financials, Employees ...
About Phase4 Ventures Phase4 Ventures is a leading venture capital firm based in London that invests in development stage life science companies in the US and Europe. Founded in 1999, …See details»
Phase4 Partners - Company Profile & Staff Directory | ContactOut
Long known as one of the leading life science venture capital firms based in Europe, Phase4 Partners, formerly known as Phase4 Ventures, has more recently expanded its mission to …See details»
Venture Capital Funding in the Life Sciences: Phase4 Ventures – A …
Jun 12, 2014 Long known as one of the leading life science venture capital firms based in Europe, Phase4 Partners, formerly known as Phase4 Ventures, has more recently expanded …See details»
PHASE4 Investments
PHASE4 Investments partners with purpose-driven startups and small companies (5-50 employees), using a structured formula to investment criteria, use-of-proceeds, and operating model.See details»
PHASE4 VENTURES III LP - Companies House
Nov 30, 2010 PHASE4 VENTURES III LP - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, …See details»
Phase4 Partners | Institution Profile | Private Equity International
Phase4 Partners overview Founded in 1999, Phase4 Partners (formerly known as Phase4 Ventures), was a London-based private equity firm that specialises in early-stage investments …See details»
Phase4 Ventures – Investors Database – Unicorn Nest
Summary Phase4 Ventures is the famous VC, which was founded in 1999. The main department of described VC is located in the London. The company was established in Europe in United …See details»
Nomura Phase4 Ventures - Private Equity Firm Profile
Phase4 Ventures is a late stage investor in emerging healthcare companies. Typically this means the companies are in the second or third financing rounds, where an IPO is foreseeable over a …See details»
Phase4 Ventures - Investments, Portfolio & Company Exits
Aug 6, 2009 Phase4 Ventures is a venture capital firm based in London that invests in development stage life science companies in the US.See details»
ASTRAZENECA AND NOMURA PHASE4 VENTURES ANNOUNCE
About Nomura Phase4 Ventures Nomura Phase4 Ventures is an active global life science investor whose mission is to provide a premium rate of return for investors by creating, identifying and …See details»
Phase4 Ventures spins out from Nomura and partners with …
Feb 10, 2011 Phase4 Ventures, the Life Science venture capital business of Nomura, has been acquired by its management team, and a significant portion of its assets under management …See details»
Phase4 Partners – Fund and Executive Details
Phase4 Partners is a venture capital company based in London, United Kingdom. They have less than $150 million in assets under management and operate 1 private fund.See details»
Nomura Spins Off Phase4 Ventures - Institutional Investor
Feb 9, 2011 Phase4 Ventures will run the new fund, Phase4 Ventures III, for HarbourVest and an existing fund for Nomura. The firm and its team, led by Denise Pollard-Knight, will continue …See details»
Phase4 VC spins out of Nomura with increased European focus
Feb 9, 2011 European biotech and medtech companies will be a primary focus for Phase4 Ventures, the life sciences venture capital business that has just been acquired by its …See details»
Phase4 Partners - Investments, Portfolio & Company Exits
Long known as one of the leading life science venture capital firms based in Europe, Phase4 Partners, formerly known as Phase4 Ventures,See details»
Denise Scots-knight | Alberio | Sweden - OMICS International
Denise Scots-Knight is CEO and co-Founder of Mereo BioPharma. She is also Managing Partner for Phase4 Partners (formerly known as Phase4 Ventures), where she has bee..See details»
Prayer ventures: April 1 - Living Lutheran
5 days ago Every day, Living Lutheran offers a prayer from the ELCA resource Prayer ventures. These daily petitions are offered as a guide for your own prayer life as together we pray for the …See details»